Kura Oncology获得与Kyowa Kirin合作的AML Menin抑制剂项目第二笔3000万美元开发里程碑支付

投资观察
Nov 20

11月4日 - Kura Oncology Inc宣布,其在与Kyowa Kirin合作的AML Menin抑制剂项目中获得第二笔3000万美元的开发里程碑支付。Kura Oncology Inc预计将在未来获得最多3.15亿美元的额外里程碑资金。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10